TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Historical Holders from Q4 2021 to Q3 2025

Symbol
TXMD on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11,549,491
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3,303,788
Holdings value
$3,542,705
% of all portfolios
0%
Number of holders
43
Number of buys
8
Number of sells
-11
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Clearline Capital LP 5.5% $705,096 635,222 Clearline Capital LP 31 Dec 2024

Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3,303,788 $3,542,705 +$51,253 $1.08 43
2025 Q2 3,255,627 $3,776,528 -$96,760 $1.16 39
2025 Q1 3,343,589 $3,092,849 -$161,728 $0.925 39
2024 Q4 3,528,745 $3,034,778 +$127,744 $0.86 38
2024 Q3 3,379,026 $5,609,223 -$32,659 $1.66 34
2024 Q2 3,408,566 $5,487,879 -$167 $1.61 34
2024 Q1 3,377,053 $7,732,812 +$286,534 $2.29 43
2023 Q4 3,251,877 $7,316,577 -$358,133 $2.25 36
2023 Q3 2,987,555 $9,324,433 +$112,168 $3.02 36
2023 Q2 3,031,054 $12,488,021 -$296,992 $4.12 40
2023 Q1 3,115,140 $11,682,289 -$1,635,363 $3.75 38
2022 Q4 3,475,915 $19,431,091 +$6,039,029 $5.59 43
2022 Q3 2,070,807 $13,750,198 -$489,469 $6.64 29
2022 Q2 1,993,507 $19,835,726 +$19,831,622 $9.95 36
2022 Q1 10,800 $4,104 +$304 $0.38 2
2021 Q4 10,000 $3,555 $0.3555 1